• HOME
• CONTACTS
• LINKS
• QUALITY STANDARDS
• INSTRUCTIONS FOR USE
• AWARDS

• Products
  by Organism
   
• Products
  by Category
   
• Product
  List
   
• Material
  Safety Data
  Sheets
• Technical
  Support
   
• Latest
  News
   
• Exhibitions
   
   
• Quality
  Certificates
   
• Careers
   
   

IMAGEN™ INFLUENZA VIRUS A AND B KIT

Code: K610511

Introduction
IMAGEN™ Influenza virus A and B is a qualitative direct immunofluorescence test for the detection and differentiation of Influenza A virus and Influenza B virus.

50 tests

Principle of the Test
IMAGEN™ Influenza virus A and B is a qualitative direct immunofluorescence test for the detection and differentiation of Influenza A virus and Influenza B virus in clinical specimens or for the confirmation and differentiation of Influenza virus A and B in cell cultures.
Influenza A and B viruses are members of the genus Influenza virus classified within the family Orthomyxoviridae.
In humans Influenza A and B infections can cause acute and occasionally severe respiratory disease in both immunocompetent and immunocompromised individuals. Infections occur in annual epidemics often with rapid onset and spread of infection. These epidemics may occur as small localised outbreaks or as worldwide epidemics depending on the type of strain prevalent.
Transmission of influenza infection occurs through inhalation of virus-laden droplets from respiratory secretions of symptomatic or asymptomatic carriers. The period of peak viral shedding occurs from 1 day before, to 3-4 days after the onset of illness.
The spectrum of respiratory disease may vary from mild upper respiratory disease to a severe pneumonia. Acute pneumonia due to Influenza A or B can be fatal particularly when associated with concomitant or secondary microbial infections in elderly or immunocompromised patients. Influenza viruses have been associated with nosocomial outbreaks of respiratory tract infections in paediatric and geriatric wards resulting in prolonged hospitalisation and increased morbidity and mortality.
The rapid laboratory diagnosis of Influenza A or B virus infections plays an important role in patient management, influencing the use of antiviral therapy and enabling effective management and control of outbreaks.
IMAGEN™ Influenza virus A and B is a direct immunofluorescence test for the detection and identification of Influenza virus strains A and B in clinical specimens or cell cultures. The test utilises species-specific monoclonal antibodies to detect epitopes of Influenza virus glycoproteins and fusion proteins specific to either Influenza virus type A or Influenza virus type B.